Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study
- PMID: 16404426
- PMCID: PMC2361124
- DOI: 10.1038/sj.bjc.6602936
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study
Abstract
Insulin-like growth factor I (IGF-I) stimulates cell proliferation and can enhance the development of tumours in different organs. Epidemiological studies have shown that an elevated level of circulating IGF-I is associated with increased risk of breast cancer, as well as of other cancers. Most of circulating IGF-I is bound to an acid-labile subunit and to one of six insulin-like growth factor binding proteins (IGFBPs), among which the most important are IGFBP-3 and IGFBP-1. Polymorphisms of the IGF1 gene and of genes encoding for the major IGF-I carriers may predict circulating levels of IGF-I and have an impact on cancer risk. We tested this hypothesis with a case-control study of 807 breast cancer patients and 1588 matched control subjects, nested within the European Prospective Investigation into Cancer and Nutrition. We genotyped 23 common single nucleotide polymorphisms in IGF1, IGFBP1, IGFBP3 and IGFALS, and measured serum levels of IGF-I and IGFBP-3 in samples of cases and controls. We found a weak but significant association of polymorphisms at the 5' end of the IGF1 gene with breast cancer risk, particularly among women younger than 55 years, and a strong association of polymorphisms located in the 5' end of IGFBP3 with circulating levels of IGFBP-3, which confirms previous findings. Common genetic variation in these candidate genes does not play a major role in altering breast cancer risk in Caucasians.
Figures

Similar articles
-
Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2316-25. doi: 10.1158/1055-9965.EPI-04-0874. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214911
-
Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2877-87. doi: 10.1158/1055-9965.EPI-10-0507. Epub 2010 Sep 1. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20810604 Free PMC article.
-
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).PLoS One. 2008 Jul 2;3(7):e2578. doi: 10.1371/journal.pone.0002578. PLoS One. 2008. PMID: 18596909 Free PMC article.
-
Insulin-like growth factor-I and binding protein-3 and risk of cancer.Horm Res. 1999;51 Suppl 3:34-41. doi: 10.1159/000053160. Horm Res. 1999. PMID: 10592442 Review.
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2116-2125. doi: 10.1158/1055-9965.EPI-22-0505. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36464995 Free PMC article.
Cited by
-
Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients.Biomedicines. 2023 Nov 28;11(12):3166. doi: 10.3390/biomedicines11123166. Biomedicines. 2023. PMID: 38137390 Free PMC article.
-
IGF gene polymorphisms and breast cancer in African-American and Hispanic women.Int J Oncol. 2011 Jun;38(6):1663-73. doi: 10.3892/ijo.2011.990. Epub 2011 Mar 30. Int J Oncol. 2011. PMID: 21455574 Free PMC article.
-
Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancer.Curr Oncol. 2016 Feb;23(1):e17-23. doi: 10.3747/co.23.2835. Epub 2016 Feb 18. Curr Oncol. 2016. PMID: 26966408 Free PMC article.
-
IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):255-7. doi: 10.1158/1055-9965.EPI-07-2588. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18199734 Free PMC article. No abstract available.
-
Effects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility.PLoS One. 2016 Sep 15;11(9):e0162970. doi: 10.1371/journal.pone.0162970. eCollection 2016. PLoS One. 2016. PMID: 27631779 Free PMC article.
References
-
- Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265 - PubMed
-
- Bingham S, Riboli E (2004) Diet and cancer – the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4: 206–215 - PubMed
-
- Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS (1998) Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9: 570–573 - PubMed
-
- Bruning PF, Van Doorn J, Bonfrer JM, Van Noord PA, Korse CM, Linders TC, Hart AA (1995) Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62: 266–270 - PubMed
-
- Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563–566 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous